WHAT IT IS TRYING TO CHANGE
What the project is doing
AgelessRx rapamycin research programme is being developed as part of the wider effort to prevent, delay or repair age-related decline.
What this could do for you
If the effect in people is large enough, this could become a medicine used to slow one or more processes that drive age-related decline.
What has to happen next
Independent evidence, price, provider quality and wider access are the next things to watch.
What could stop it
Being available does not prove that it extends life. Benefit, risk, provider quality and total cost still need to be checked.